Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**TATA box-binding protein-like 1 (TBPL1)** is a member of the TATA box-binding protein family and is encoded by the TBPL1 gene in humans. Unlike the canonical TATA-binding protein (TBP), TBPL1 does not bind the TATA box sequence but can initiate transcription from TATA-less promoters[2]. It plays a key role in transcriptional regulation, especially for genes lacking a canonical TATA box. TBPL1 is essential in spermatogenesis and may be important for the expression of certain developmentally regulated genes[1][2]. While it shares homology with TBP, TBPL1 serves specialized functions and does not bind to the same promoter elements as TBP or associate with the full TFIID complex. Currently, TBPL1 is not considered a therapeutic target, nor are there known drugs or established biomarkers directly linked to its function or modulation[2][1]. **Note:** - TBPL1 is distinct from TATA-box binding protein (TBP) and other TBP-like factors such as TRF3, TRF1, and TRF2[4]. - Interactions include binding to other general transcription factors, such as GTF2A1[1]. - The gene has alternate transcripts and a pseudogene on chromosome 3[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TATA box-binding protein-like 1 (TBPL1).